UHRF1 and neoplasm: Studies have shown that the upregulation of UHRF1 expression or enhanced function promotes the epigenetic silencing of tumor suppressor genes (TSGs), thereby facilitating tumor progression and drug resistance in tumors [14, 20, 21].